Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

228 results about "Restriction enzyme" patented technology

A restriction enzyme, restriction endonuclease, or restrictase is an enzyme that cleaves DNA into fragments at or near specific recognition sites within molecules known as restriction sites. Restriction enzymes are one class of the broader endonuclease group of enzymes. Restriction enzymes are commonly classified into five types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another. To cut DNA, all restriction enzymes make two incisions, once through each sugar-phosphate backbone (i.e. each strand) of the DNA double helix.

High-stability recombinant XVII type collagen as well as construction method and application thereof

The invention provides a high-stability recombinant XVII type collagen as well as a construction method and application thereof, and belongs to the technical field of bioengineering. According to the invention, an amino acid sequence of natural human (XVII) type collagen is selected as a basic unit and repeated for multiple times to obtain recombinant (XVII) type collagen; in the design process of the recombinant XVII type collagen, an unstable GXY triad is avoided, potential matrix metalloproteinase restriction enzyme cutting sites and glycosylation sites are abandoned, a KGD active sequence is reserved, and the probability of containing sites which are easy to degrade can be reduced; a sequence fragment of the recombinant XVII type collagen is derived from a full-length sequence of a natural collagen gene, has excellent solubility, biological activity and high stability, and can be kept stable in a high-temperature storage environment and under the condition of avoiding alkalinity; the product can be used as a raw material in the production process of medicines, medical equipment, biological materials or cosmetics, and has good practicability.
Owner:JIANGSU TRAUTEC MEDICAL TECH CO LTD

Tryptamine hydroxylase mutant and application thereof

The invention provides a tryptamine hydroxylase mutant and application thereof. The tryptamine hydroxylase mutant is selected from any one of the following amino acid sequences: (a) the tryptamine hydroxylase mutant is obtained by deleting 30-45 amino acids from the N terminal of tryptamine hydroxylase as shown in SEQ ID NO: 1, and (b) the tryptamine hydroxylase mutant is obtained by deleting 30-45 amino acids from the N terminal of tryptamine hydroxylase as shown in SEQ ID NO: 2; (b) is formed by mutation of the amino acid sequence shown in (a), mutation sites are selected from one or more of the following amino acid residue sites: the 114 site, the 133 site, the 247 site, the 309 site, the 401 site and the 464 site, and the positions of the mutation sites correspond to the wild tryptamine hydroxylase with the sequence of SEQ ID NO: 1; (c) an amino acid sequence obtained by adding a tag sequence, a restriction enzyme cutting site sequence or a signal sequence to one end or two ends of (a) or (b). The catalytic activity of the tryptamine hydroxylase mutant is greatly improved compared with that of a wild enzyme, and the yield of 5-hydroxytryptamine is remarkably improved.
Owner:HEBEI WEIDAKANG BIOTECHNOLOGY CO LTD

Cathepsin B activated fluorescent probe, nanoparticles and application

The invention discloses a cathepsin B activated fluorescent probe which comprises a dicyanoisosulfone fluorescent report unit and a cathepsin B specific restriction enzyme cutting site GFLG peptide chain. When CTSB specifically cuts a GFLG peptide chain, a DCO molecule with an amino group with relatively strong electron donating ability is generated, so that the fluorescence emission behavior of the probe is rapidly activated through a one-step enzyme catalysis reaction. The invention also provides a preparation method of the cathepsin B activated fluorescent probe. The invention also provides a nano particle for packaging the cathepsin B activated fluorescent probe, and the nano particle is simple in preparation process and mild in reaction condition. The cathepsin B activated fluorescent probe is prepared into nanoparticles, and the nanoparticles can realize accumulation of the material in tumor tissues and accurate imaging in apoptotic tumor cells by enhancing the permeation retention effect, have better biocompatibility and can be used for detecting the apoptotic tumor cells.
Owner:HANGZHOU NORMAL UNIVERSITY

Method for improving gas-liquid interface property of yeast protein

The invention belongs to the technical field of yeast protein processing, and particularly relates to a method for improving the gas-liquid interface property of yeast protein. The method comprises the following steps: dispersing yeast protein in water to obtain a yeast protein dispersion liquid; adjusting the temperature and the pH value of the yeast protein dispersion liquid, stabilizing for a period of time, then carrying out restriction enzyme hydrolysis, and centrifuging after enzyme deactivation to obtain supernate. The surface tension of the yeast protein obtained by the method is reduced, the foaming ability and the foam stability are remarkably improved, and bubbles generated by whipping are small and uniform. And the method is green and efficient, and is beneficial to full utilization of high-quality protein resources.
Owner:INST OF AGRO FOOD SCI & TECH CHINESE ACADEMY OF AGRI SCI

Preparation method and application of large intestine expression recombinant A-type botulinum toxin

The invention provides a preparation method, application and the like of large intestine expression recombinant A-type botulinum toxin (BONT / A). The recombinant BONT / A nucleic acid expression cassette comprises a tag, a restriction enzyme cutting site and a BONT / A nucleic acid sequence, and an exogenous protease recognition site is not introduced between a BONT / A light chain and a BONT / A heavy chain. The invention also provides a recombinant vector containing the nucleic acid expression cassette, a recombinant bacterium, a coded and expressed protein and the like, the prepared recombinant BONT / A does not introduce exogenous amino acid or only introduces two amino acids at one position, and the consistency of the recombinant BONT / A with the natural A-type botulinum toxin is ensured to the greatest extent. Through novel molecular design and preparation process, the recombinant reBONT / A with higher toxicity and low immunogenicity is efficiently obtained, and wide industrial application is facilitated.
Owner:YAOHAI BIOTECHNOLOGY (BEIJING) CO LTD

FBXO32 gene SNP (Single Nucleotide Polymorphism) marker for rapidly detecting economic traits of Tibetan chicken, detection method and application

The invention belongs to the field of molecular biological detection, and particularly relates to an FBXO32 gene SNP (Single Nucleotide Polymorphism) marker for rapidly detecting economic traits of Tibetan chicken as well as a detection method and application. It is found for the first time that G / A mutation at the 8916th site of the Tibetan chicken FBXO32 gene is closely related to whether the gene has an Hpa II restriction enzyme cutting site or not, and is closely related to main economic traits of Tibetan chicken. Based on the new discovery and the SNP site, the invention provides a method for rapidly detecting the SNP site and screening economic characters of Tibetan chicken. The method is simple to operate, convenient and fast, low in cost and reliable in result.
Owner:SOUTHWEST UNIVERSITY FOR NATIONALITIES

Methods of producing DNA templates for mRNA production

The invention provides a method for producing a DNA template for mRNA containing a polyadenylate tail. This method is applicable to in vitro transcription reactions, generating mRNA with a specific polyadenylate tail length. Additionally, the invention further provides a method for extending the polyadenylate tail sequence using terminal deoxynucleotidyl transferase and combinations of restriction enzymes. This ensures that in in vitro transcription reactions, the mRNA can precisely terminate at the polyadenylate tail, thereby improving the accuracy and efficiency of mRNA synthesis.
Owner:SMOBIO TECH

PLS3 gene SNP (Single Nucleotide Polymorphism) marker for rapidly detecting economic traits of Tibetan chicken, detection method and application

ActiveCN120967014AMicrobiological testing/measurementFood processingRestriction Enzyme Cut SiteMedicine
The invention belongs to the field of molecular biological detection, and particularly relates to a PLS3 gene SNP marker for rapidly detecting economic traits of Tibetan chicken, a detection method and application. It is found for the first time that G / A mutation at the 28469th site of the Tibetan chicken PLS3 gene is closely related to whether the gene has a BstZ17 I restriction enzyme cutting site or not, and is closely related to main economic traits of Tibetan chicken. Based on the new discovery and the SNP site, the invention provides a method for rapidly detecting the SNP site and screening economic characters of Tibetan chicken. The method is simple to operate, convenient and fast, low in cost and reliable in result.
Owner:SOUTHWEST UNIVERSITY FOR NATIONALITIES

Fusion gene of grass carp NPM1a and II type reovirus VP38, recombinant protein, composition and application

The invention relates to the technical field of aquaculture fish vaccines, in particular to a fusion gene of grass carp NPM1a and II type reovirus VP38, recombinant protein, a composition and application. The nucleotide sequence of the fusion gene is as shown in SEQ ID NO: 1. The fusion gene is obtained by connecting grass carp NPM1a and II type reovirus VP38 through a linker sequence, a BamH restriction enzyme cutting site is added to the 5'end of the fusion sequence, and an XhoI restriction enzyme cutting site is added to the 3 'end of the fusion sequence; the sequence of the linker is as shown in SEQ ID NO: 2. The subunit vaccine of the fusion protein of the grass carp NPM1a and the II type reovirus VP38 is prepared, and indole-3-lactic acid is used as an immunopotentiator in a combined manner, so that the technical bottlenecks of low protection rate, poor intestinal mucosal barrier repairability and the like of the existing vaccine are overcome.
Owner:HUNAN NORMAL UNIVERSITY

Wheat bionic peptide as well as biosynthesis method and application thereof

The invention belongs to the technical field of biology, and discloses a wheat bionic peptide and a biosynthesis method and application thereof, and the method comprises the following steps: carrying out amino acid sequence analysis on a protein sequence of a target wheat peptide, and determining a target nucleotide sequence corresponding to a coded same protein sequence according to codon degeneracy; optimizing the target nucleotide sequence according to password preference of escherichia coli to obtain a wheat bionic peptide nucleotide sequence; treating and combining the obtained wheat bionic peptide nucleotide sequence and a vector plasmid through restriction enzyme to construct a recombinant plasmid; transferring the recombinant plasmid into host bacteria, performing fermentation culture to induce protein expression, separating protein, and purifying to obtain the wheat biomimetic peptide. The wheat biomimetic peptide is obtained in a biosynthesis mode, and compared with plant extraction and chemical synthesis, the cost is reduced, and meanwhile, the safety of the product is guaranteed.
Owner:BEIJING YANZHISHAN TECH CO LTD

Novel dipeptide synthetase and application thereof

The invention discloses a dipeptide synthetase and application thereof, and relates to the technical field of biology, and the nucleotide sequence of the dipeptide synthetase is as shown in SEQ ID NO: 1; the method comprises the following steps: cloning a dipeptide synthetase gene from streptomyces albogriseolus 1-36 by virtue of a PCR (Polymerase Chain Reaction) technology; the recombinant plasmid is connected to NcoI and XhoI restriction enzyme cutting sites of a high-efficiency expression vector pET-28a (+), and is transformed into competent cells of escherichia coli DH5alpha, and plasmids are extracted; and transforming to an expression host strain BL21 (DE3) to obtain a genetic engineering strain for efficiently expressing the dipeptide synthetase. The dipeptide synthetase is applied to synthesis of a dipeptide compound or synthesis of a compound taking the dipeptide compound as a precursor. The dipeptide synthetase obtained by the invention can identify carboxyl donors and amino donors from non-natural amino acids to generate dipeptide compounds, and has the advantages of mild enzyme catalysis conditions and high catalysis efficiency.
Owner:SHANGHAI JIAOTONG UNIV

High-stability recombinant I-type collagen and application thereof

ActiveCN119661692AImprove stabilityReduce the difficulty of purificationCosmetic preparationsFungiAssociated organismEngineering
The invention provides high-stability recombinant I-type collagen and application thereof, and belongs to the technical field of collagen. The invention aims to avoid potential restriction enzyme cutting sites and unstable sequence fragments during sequence design through directional selection of the existing amino acid sequence, so that the amino acid sequence can be efficiently expressed in pichia pastoris, and the recombinant I-type collagen obtained after purification has very high stability; the recombinant I-type collagen gives consideration to factors such as related biological active sites, hydrophilicity and the like, has related biological activity while being relatively high in stability, and has very good practicability.
Owner:JIANGSU TRAUTEC MEDICAL TECH CO LTD

Method for simultaneously determining gene point mutation and DNA methylation based on CRISPR / Cas12a system

The invention discloses a method for simultaneously determining gene point mutation and DNA methylation based on a CRISPR / Cas12a system. The method is characterized by comprising four steps of enzyme digestion, recognition, conversion and detection, wherein in the enzyme digestion step, methylation-sensitive restriction endonuclease (MSRE) is selected according to a target site sequence, unmethylated DNA is not hydrolyzed by MSRE and is kept complete, methylated DNA is hydrolyzed and broken under the action of MSRE, and the broken 3'end can be used as a primer P1 to trigger SDA1 amplification; wherein in the recognition step, a Flap primer and an Invading primer are designed according to a point mutation sequence, and an enzyme digestion product generated under the action of FEN1 enzyme can be used as a primer P2 to trigger SDA2 amplification; wherein in the conversion step, two different SDA amplification templates are designed according to sequences of P1 and P2, and amplification of SDA1 and SDA2 is triggered by enzyme digestion products P1 and P2 respectively, so that DNA methylation and gene mutation information are quickly converted into two different amplification products T1 and T2; wherein in the detection step, crRNA1 and crRNA2 are respectively designed as guide chains of a CRISPR / Cas12a reaction system according to sequences of T1 and T2, and synchronous detection of gene point mutation and DNA methylation is realized through'strong 'and'weak' of fluorescence signals. Based on a CRISPR / Cas12a system, the method solves the problem that a traditional detection method cannot realize simultaneous detection of gene point mutation and DNA methylation, can be used for scientific research analysis and clinical detection, and has a wide market prospect.
Owner:ZHENGZHOU UNIV

Micro-ring plasmid synthesis method

The invention discloses a micro-ring plasmid synthesis method, and belongs to the technical field of gene editing. Two pairs of primers are designed, eukaryotic expression plasmids containing selection markers and target fragments are used as templates for PCR amplification to obtain two target fragments, vector plasmids loxp-R6K with specific sequences and the target fragments form recombinant plasmids, the recombinant plasmids contain sequences such as the target fragments, restriction enzyme cutting sites and R6K replication start sites, and the recombinant plasmids are used for preparing the recombinant plasmids. The recombinant plasmid is transformed in Escherichia coli GT115 competent cells, the recombinant plasmid is verified to have the recombination efficiency of 81% after bacterial colony PCR amplification, a correctly cloned seed solution is screened and subjected to induced expression to form a bacterial solution containing a screening-label-free micro-plasmid, the micro-ring plasmid is separated and purified, and the screening-label-free micro-ring plasmid is obtained. The sequence of the microring plasmid only contains a target fragment and an R6K replication start site, the accuracy of the size sequence of the microring plasmid in a bacterial colony cultured and cloned by the microring plasmid is as high as 90%, and the microring plasmid can be efficiently and stably obtained.
Owner:GENERAL BIOL (ANHUI) CO LTD

Matrix metalloproteinase-responsive multifunctional bionic ferritin nano material as well as preparation method and application thereof

The invention discloses a matrix metalloproteinase-responsive multifunctional bionic ferritin nano material as well as a preparation method and application thereof. The method comprises the following steps: modifying melittin on the surface of a ferritin nanoparticle through a genetic engineering method, connecting by using a linker containing a matrix metalloproteinase 9 (MMP-2 / 9) restriction enzyme cutting site, expressing the obtained recombinant ferritin (SEQ ID NO: 6) in escherichia coli, and self-assembling to form the enzyme response functionalized bionic nanoparticle. According to the method, melittin can be connected to ferritin nanoparticles in series, the toxicity of melittin is remarkably reduced, and the melittin responds to matrix metalloproteinase in a tumor microenvironment so as to kill tumor cells; meanwhile, intravenous administration of melittin can be realized, and the melittin injection has a good treatment effect on in-situ and metastatic tumors.
Owner:SOUTH CHINA UNIV OF TECH

CAPS molecular marker of rice salt-tolerant ST4 promoter region and application of CAPS molecular marker

The invention relates to the technical field of agriculture, and particularly provides a CAPS molecular marker of a rice salt-tolerant ST4 promoter region and application of the CAPS molecular marker. The method comprises the following steps: selecting leaves of rice to extract genome DNA (Deoxyribonucleic Acid) of the tissues, and then respectively carrying out PCR (Polymerase Chain Reaction) amplification by taking the DNA of the tissues as a template and taking corresponding sequences of ST4-PRO-F1 and ST4-PRO-R1 as specific primers to obtain amplified fragments; carrying out enzyme digestion on the amplified fragment by using Eco81I restriction enzyme, and carrying out electrophoresis after enzyme digestion; after the ST4 promoter fragment is subjected to electrophoresis, a single plant with only one 2162bp main band is a salt-tolerant single plant, and a single plant with 1366bp and 784bp bands appearing in electrophoresis is a salt-sensitive single plant. According to the invention, the rice variety improved by utilizing the wild rice ST4 gene can be rapidly bred, the current situations of much field work and large workload caused by carrying out a large amount of salt tolerance identification by utilizing a population material can be improved, and the method has important theoretical and practical significance for breeding a new variety of rice with salt tolerance character.
Owner:INSTITUTE OF CROP SCIENCE CHINESE ACADEMY OF AGRICULTURAL SCIENCES

ITR deletion detection method

The invention relates to a method for detecting deletion in ITR to be detected contained in an AAV vector to be detected. The method comprises the following steps: cutting a fragment containing a sequence of the ITR to be detected from the AAV vector to be detected by using restriction enzyme, detecting the size of the fragment of an enzyme digestion product, and determining whether deletion exists in the ITR to be detected according to the size of the fragment.
Owner:NANJING GENSCRIPT BIOTECH CO LTD

MeDIP-MSRE-based whole genome methylation detection method

The invention discloses a whole genome methylation detection method based on MeDIP-MSRE, and belongs to the technical field of epigenetics detection. According to the method, methylation immunoprecipitation sequencing and a methylation sensitive restriction enzyme technology are innovatively combined, firstly, a methylation specific antibody is used for conducting immunoprecipitation on sample DNA, and whole genome methylation fragments are enriched; then carrying out enzyme digestion on the enriched product by adopting methylation sensitive restriction enzyme, specifically removing an unmethylated DNA region, and reserving a complete methylation sequence; and finally, constructing a methylation map through high-throughput sequencing. According to the method, traditional hydrosulfite chemical conversion is not needed, DNA damage and base conversion deviation caused by the traditional hydrosulfite chemical conversion are avoided, meanwhile, high sensitivity of MeDIP and high specificity of methylation sensitive restriction endonuclease are fused, and the fidelity, sensitivity and specificity of detection are remarkably improved.
Owner:ZHONGKE JINCHEN BIOTECHNOLOGY (HEFEI) CO LTD

Methylation marker for diagnosis of diabetic nephropathy

The invention relates to the technical field of molecular biology, in particular to a methylation marker for diagnosis of diabetic nephropathy. Specifically, the methylation marker comprises a P site of a CAT gene promoter region and / or an E site of a CAT gene exon 1 region. Based on a detection system combining methylation sensitive restriction enzyme with quantitative PCR, the kit has the advantages of simplicity and convenience in operation, good repeatability, accuracy in quantification and easiness in standardization, and is suitable for low-invasive samples such as peripheral blood. By effectively distinguishing pure type 2 diabetes patients from diabetic nephropathy combined patients, a reliable technical means is provided for risk stratification, early intervention and dynamic monitoring of diabetic people, and the method has good clinical application prospects and popularization value.
Owner:CHINA JAPAN FRIENDSHIP HOSPITAL

Sample preparation for cell-free DNA analysis

Methods for the processing and analysis of blood samples obtained with blood collection tubes that reduce contamination of cfDNA by genomic DNA but that inhibit digestion by methylation-sensitive and / or methylation-dependent restriction enzymes.
Owner:NUCLEIX LTD

MRNA analysis using restriction enzymes

The present disclosure describes methods, kits, and systems for digesting polyribonucleotides. The methods involve selectively forming an oligonucleotide (e.g., DNA: RNA or RNA: RNA) duplex with a single-stranded target RNA, and then selectively cleaving the target RNA into smaller fragments using a sequence-specific nuclease that acts only on the RNA within the duplex. Additional sequence-specific ribonucleases can be used to provide additional cleavage of the target RNA at a predetermined site. By forming double strands to increase the availability of nuclease enzymes that can be used to cleave the single-stranded target RNA and to selectively control the location at which the target RNA is cleaved, the target RNA can be digested into fragments within a controllable size range that are optimal for polynucleotide analysis, such as by liquid chromatography and mass spectrometry.
Owner:WATERS TECHNOLOGY CORP

DCAPS molecular marker primer linked with brassica napus saline-alkaline tolerance gene BnaC03.RBGB3 and application of dCAPS molecular marker primer

The invention discloses a dCAPS molecular marker primer linked with a brassica napus saline-alkaline tolerance gene BnaC03.RBGB3 and application of the dCAPS molecular marker primer. The primer comprises a forward primer and a reverse primer, and through PCR amplification and specific restriction enzyme digestion treatment, two genotypes of high resistance and high sensitivity of brassica napus saline-alkaline tolerance can be distinguished on agarose gel electrophoresis; the high-resistance genotype is represented by two electrophoretic bands (195bp and 23bp), and the high-sensitivity genotype is a band which cannot be digested by enzyme. The method disclosed by the invention is simple and convenient to operate and reliable in result, can be used for rapidly screening and identifying the saline-alkaline-tolerant variety of the brassica napus, and provides a powerful tool for breeding the saline-alkaline-tolerant variety of the brassica napus. By implementing the technology, not only is the breeding efficiency improved, but also a new thought and strategy are provided for molecular marker-assisted breeding of saline-alkaline tolerance of crops, and development and application of a saline-alkaline tolerance breeding technology of brassica napus and even other crops are promoted.
Owner:NORTHWEST A & F UNIV

DCAPS molecular marker for identifying sweet potato pulp color character and application of dCAPS molecular marker

The invention discloses a dCAPS molecular marker for identifying sweet potato pulp color characters and application of the dCAPS molecular marker, and belongs to the technical field of sweet potato breeding. According to the dCAPS molecular marker provided by the invention, on the basis of SNP variation sites, mismatched bases are introduced to form restriction endonuclease restriction enzyme cutting sites, the sweet potato pulp color can be judged by utilizing PCR-restriction enzyme cutting-polyacrylamide gel electrophoretic separation, and then sweet potato varieties with high and low carotenoid contents can be identified according to the sweet potato pulp color. The method has important guiding significance and application value for assisting sweet potato carotenoid content related molecular breeding research.
Owner:CHINA AGRI UNIV

Methods for detecting methylation and mutation status of DNA samples

The present disclosure provides a method for detecting the methylation and mutation status of a DNA sample, specifically, a method for simultaneously detecting the methylation and mutation status of DNA molecules in a sample, the method comprising treating the sample with a methylation-sensitive restriction enzyme, performing hybrid capture on amplification products of the restriction enzyme-treated sample and a sample that has not been subjected to enzyme cleavage treatment with a probe set including a mutation capture probe and a methylation capture probe, and sequencing the captured products.
Owner:NANODIGMBIO (NANJING) BIOTECHNOLOGY CO LTD

Methods and compositions for analyzing messenger RNA

PCT designated stage expiredWO2025012461A1Microbiological testing/measurementMessenger RNAGenetics
The present disclosure is directed to a method of determining the presence of at least one messenger RNA (mRNA) molecule in a composition, which method comprises: (a) reverse transcribing the at least one mRNA molecule to obtain a template comprising at least one first strand of complementary DNA (cDNA); (b) generating at least one double-stranded cDNA molecule from the template; (c) amplifying the at least one double-stranded cDNA molecule; (d) digesting the at least one amplified double-stranded cDNA molecule with at least one restriction enzyme to obtain test cDNA fragments; (e) separating the test cDNA fragments, to thereby form a test cDNA fragment pattern; and (f) comparing the test cDNA fragment pattern with a control cDNA fragment pattern, wherein the at least one mRNA molecule is present in the composition when the test cDNA fragment pattern comprises the control cDNA fragment pattern. Methods of quantitating and / or assessing the integrity of at least one mRNA molecule in a composition, a process of manufacturing a composition comprising at least one mRNA molecule and primer pairs for use in the present methods are also disclosed.
Owner:SANOFI PASTEUR INC

Stem-loop adapter, polynucleotide library for grna production, and methods for using same

[Problem] To provide: an adapter for binding to polynucleotide fragments that is used for preparing a genome-wide gRNA library for genome editing systems; a gRNA library that is obtained by using the adapter; and uses of the gRNA library. [Solution] An adapter having a structure described in A). A) A structure having i) to iii). i) A polynucleotide chain having sequences i)-1 to i)-3. i)-1: Sequence corresponding to the forward primer. i)-2: Sequence of the recognition site of a restriction enzyme capable of excising a gRNA spacer sequence from the 5' end of a polynucleotide fragment bound to the adapter. i)-3: Sequence of the recognition site of a restriction enzyme capable of cleaving an adapter having the structure of A) from the polynucleotide fragment. ii) A polynucleotide chain having the sequence complementary to i). iii) A single-stranded polynucleotide chain for formation of a loop connecting the 5' end of i) and the 3' end of ii) of the double strand resulting from the binding of i) and ii).
Owner:YOSHIDA KEISUKE +2

Universal bacterial artificial chromosome recombinant virus transfer vector and construction method thereof

The invention belongs to the technical field of genetic engineering, and particularly relates to a universal bacterial artificial chromosome recombinant virus transfer vector and a construction method thereof, the transfer vector comprises a BAC amplification vector with pUC19-loxp-gpt-IRES-EGFP as a basic skeleton and pUC19-BAC as a functional sequence; according to the universal bacterial artificial chromosome recombinant virus transfer vector and the construction method thereof, a drug screening target gene reading frame and an EGFP fluorescent protein gene reading frame are connected through an IRES double-expression connection sequence, and double screening can be carried out; in the BAC construction process, screening genes and functional sequences are respectively constructed to a high-copy T vector, so that sufficient plasmid DNA can be conveniently copied and prepared. And through a proper restriction enzyme cutting site, introduction of various homologous arms is facilitated, the alignment is wide, simultaneous operation of various genomic sequences is facilitated, and the research efficiency is improved.
Owner:JINYU YOUBANG BIOTECHNOLOGY (JIANGSU) CO LTD

Method and device for designing messenger ribonucleic acid sequence, computing equipment and storage medium

The invention relates to the technical field of biological pharmacy, and discloses a messenger ribonucleic acid sequence design method and device, computing equipment and a storage medium. According to the method, on the basis that a given 5 'UTR sequence serves as initial input, new codons are added one by one through a growth method, the overall-length minimum free energy and codon use efficiency of the whole sequence are calculated, scored and sorted, an elimination method is used for excluding sequences containing restriction enzyme cutting sites / poor properties / poorer scores, and finally, the sequences containing the restriction enzyme cutting sites / poor properties / poorer scores are obtained. And selecting representative sequences by using a cluster clustering search method to increase diversity, and finally obtaining the sequences for recommendation synthesis. The invention provides an mRNA sequence optimization design method in an environment with 5 'UTR and 3' UTR, the full-length minimum free energy of an mRNA sequence and the codon use efficiency of a CDS region are considered, the two targets can be optimized at the same time, the stability can be optimized from the perspective of overall molecules, the expressibility of the CDS region is optimized at the same time, and the method has the advantages of being simple in structure, convenient to operate and the like. And the stability and expressibility of the mRNA sequence are ensured.
Owner:ZHIYAO TECH

Method and device for simulating pulsed field gel electrophoresis band based on sequencing technology

PendingCN121354661AMicrobiological testing/measurementData visualisationRestriction Enzyme Cut SiteEndonuclease
The invention provides a method and a device for simulating a pulsed field gel electrophoresis band based on a sequencing technology. The method for simulating the pulsed field gel electrophoresis band based on the sequencing technology comprises the following steps: acquiring nanopore sequencing data of a biological sample to be analyzed, and assembling based on the nanopore sequencing data to obtain a genome sequence; according to the sequence characteristics of the restriction endonuclease, identifying a restriction enzyme cutting site corresponding to the restriction endonuclease from the genome sequence; when the restriction enzyme cutting site is the restriction enzyme cutting site subjected to methylation modification, removing the restriction enzyme cutting site to obtain a residual restriction enzyme cutting site; calculating the distance difference between two adjacent restriction enzyme cutting sites according to all residual restriction enzyme cutting sites, and taking the distance difference as the molecular weight of a simulated band; aiming at the molecular weight of each simulated strip, determining a strip position corresponding to the molecular weight; and drawing a simulated pulse field gel electrophoresis band result according to the position of each band and the molecular weight corresponding to the band position so as to accurately simulate the band result.
Owner:ZHEJIANG CENT FOR DISEASE CONTROL & PREVENTION +1

Methods and compositions for amplifying methylated target DNA molecules

The present disclosure provides methods and compositions for preparing DNA molecules useful for determining the methylation status of selected regions of a DNA molecule, which utilize methylation-sensitive restriction enzymes and typically involve the amplification or selective enrichment of one or more target regions.
Owner:NATERA INC